BioMarin Pharmaceutical Inc. · 1 month ago
Research and Early Development Postdoctoral Fellowship
San Rafael, CA
Full-time
Onsite
New GradBioMarin Pharmaceutical Inc. is a world leader in delivering therapeutics for patients with rare genetic diseases. The Research and Early Development (RED) organization is seeking a Postdoctoral Fellow to conduct innovative research and support preclinical drug development across various therapeutic areas.
BiotechnologyDeveloper PlatformPharmaceutical
Responsibilities
Design and conduct experiments or studies in collaboration with the Fellowship advisor and/or RED or Clinical colleagues to identify and explore new disease biology, indications, modalities, or technologies, or to advance a pipeline program or platform
Provide scientific and intellectual input to guide project-related proof-of-concept and investigative efforts within the context of interdisciplinary project teams
Where appropriate, initiate, direct and execute the development, optimization, and qualification of robust assays
Analyze data with applicable bioinformatics tools/scientifically sound interpretation and present data at group/departmental meetings
Troubleshoot experiments based on a thorough understanding of assay principles
Author technical reports and SOPs associated with the assays developed and qualified
Contribute to study reports and manuscripts
Provide scientific support to collaborating functional groups, as needed
Work with junior research associates and scientists on experimental design, troubleshooting, assay optimization and data interpretation, where applicable
Maintain broad knowledge of relevant state-of-the-art scientific principles and theories
Participate in exploratory studies driving the evaluation of state-of-the-art technology platforms, and innovative upgrades for existing assay platforms
Identify, develop and maintain relationships with contract research organizations to maximize project productivity and assure inclusion of latest scientific thinking and guidelines in the research plan
Contribute to the peer review process, both internally and externally, to help assure BioMarin research is conducted at the highest level of quality, integrating business and development objectives
Make meaningful contributions to the scientific literature and/or conferences
Participate in at least one governance meeting and/or regulatory engagement on a pipeline program
Present at/participate in program/platform strategy meetings
Qualification
Required
Completion of a doctoral degree in a relevant scientific discipline within three years of the program start date (June 2026); no industry experience required
Track record of success demonstrated by a strong publication record
Robust track record of demonstrating self-initiative/motivation
Highly self-motivated, detail-oriented, and possess excellent written and oral communication skills
Well-organized with the ability to be flexible and work in a fast-paced environment with competing priorities
Ability to think strategically
Strong interpersonal skills and the ability to work in a collaborative environment
Be able to navigate a new working environment in parallel with personal development
Demonstrates the skill to analyze and synthesize data with efficiency and effectiveness
Effectively deals with ambiguity and adapts quickly to change
Works independently on complex projects
Demonstrates professional maturity, treats others equitably and fairly, and is willing to adhere to BioMarin Code of Conduct
Company
BioMarin Pharmaceutical Inc.
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery.
Founded in 1997
1001-5000 employees
H1B Sponsorship
BioMarin Pharmaceutical Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (34)
2024 (23)
2023 (24)
2022 (26)
2021 (24)
2020 (19)
Funding
Current Stage
Public CompanyTotal Funding
$585.8M2020-05-11Post Ipo Debt· $585.8M
1999-07-26IPO
Leadership Team
Brian Mueller
Chief Financial Officer
Arpit Davé
Executive Vice President, Chief Digital and Information Officer
Recent News
2026-01-13
Morningstar.com
2026-01-09
Company data provided by crunchbase